Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study
- PMID: 28940184
- PMCID: PMC5729097
- DOI: 10.1111/jgs.15077
Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study
Abstract
Background/objectives: Longitudinal studies have shown an increase in cognitive decline many years before clinical diagnosis of dementia. We sought to estimate changes, relative to "normal" aging, in the trajectory of scores on a global cognitive function test-the Cognitive Abilities Screening Instrument (CASI).
Design: A prospective cohort study.
Setting: Community-dwelling members of a U.S. health maintenance organization.
Participants: Individuals aged 65 and older who had no dementia diagnosis at baseline and had at least two visits with valid CASI test score (N = 4,315).
Measurements: Average longitudinal trajectories, including changes in trajectory before clinical diagnosis in those who would be diagnosed with dementia, were estimated for CASI item response theory (IRT) scores. The impact of sex, education level, and APOE genotype on cognitive trajectories was assessed.
Results: Increased cognitive decline relative to "normal" aging was evident in CASI IRT at least 10 years before clinical diagnosis. Male gender, lower education, and presence of ≥1 APOE ε4 alleles were associated with lower average IRT scores. In those who would be diagnosed with dementia, a trajectory change point was estimated at an average of 3.1 years (95% confidence interval 3.0-3.2) before clinical diagnosis, after which cognitive decline appeared to accelerate. The change point did not differ by sex, education level, or APOE ε4 genotype. There were subtle differences in trajectory slopes by sex and APOE ε4 genotype, but not by education.
Conclusion: Decline in average global cognitive function was evident at least 10 years before clinical diagnosis of dementia. The decline accelerated about 3 years before clinical diagnosis.
Keywords: change point; cognitive function; dementia; trajectory changes.
© 2017, Copyright the Authors Journal compilation © 2017, The American Geriatrics Society.
Conflict of interest statement
We have no conflicts of interest or financial disclosures to report.
Figures
Similar articles
-
Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.Neurol Res. 2006 Sep;28(6):650-6. doi: 10.1179/016164106X130443. Neurol Res. 2006. PMID: 16945218
-
Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.Arch Neurol. 1998 Aug;55(8):1065-9. doi: 10.1001/archneur.55.8.1065. Arch Neurol. 1998. PMID: 9708956
-
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060. JAMA Psychiatry. 2014. PMID: 25162367
-
Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline.J Clin Epidemiol. 2008 Oct;61(10):1018-27.e9. doi: 10.1016/j.jclinepi.2007.11.011. Epub 2008 May 5. J Clin Epidemiol. 2008. PMID: 18455909 Free PMC article. Review.
-
A viewpoint on change point modeling for cognitive aging research: Moving from description to intervention and practice.Ageing Res Rev. 2020 Mar;58:101003. doi: 10.1016/j.arr.2019.101003. Epub 2019 Dec 24. Ageing Res Rev. 2020. PMID: 31881367 Free PMC article. Review.
Cited by
-
Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer's disease neuropathologic change.Acta Neuropathol. 2023 Mar;145(3):303-324. doi: 10.1007/s00401-022-02526-0. Epub 2022 Dec 20. Acta Neuropathol. 2023. PMID: 36538112 Free PMC article.
-
Cognitive trajectories preluding the imminent onset of Alzheimer's disease dementia in individuals with normal cognition: results from the HELIAD cohort.Aging Clin Exp Res. 2023 Jan;35(1):41-51. doi: 10.1007/s40520-022-02265-y. Epub 2022 Nov 2. Aging Clin Exp Res. 2023. PMID: 36322329 Free PMC article.
-
Related amyloid burden and cortical atrophy in individuals with subtle cognitive decline.J Neuroimaging. 2022 Nov;32(6):1075-1079. doi: 10.1111/jon.13055. Epub 2022 Sep 23. J Neuroimaging. 2022. PMID: 36151065 Free PMC article.
-
Cognitive Trajectories in Community-Dwelling Older Adults and Incident Dementia, Disability and Death: A 10-Year Longitudinal Study.Front Med (Lausanne). 2022 Jun 27;9:917254. doi: 10.3389/fmed.2022.917254. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35833102 Free PMC article.
-
Association of Posttraumatic Stress Disorder With Accelerated Cognitive Decline in Middle-aged Women.JAMA Netw Open. 2022 Jun 1;5(6):e2217698. doi: 10.1001/jamanetworkopen.2022.17698. JAMA Netw Open. 2022. PMID: 35771577 Free PMC article.
References
-
- Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, Schellenberg GD, et al. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology. 2007;69:631–639. - PubMed
-
- Amieva H, Le Goff M, Millet X, Orgogozo JM, Peres K, Barberger-Gateau P, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Annals of neurology. 2008;64:492–498. - PubMed
-
- Amieva H, Mokri H, Le Goff M, Meillon C, Jacqmin-Gadda H, Foubert-Samier A, et al. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline. Brain : a journal of neurology. 2014;137:1167–1175. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
